Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)
| CAPS Rating |
|
|---|---|
| Open | $2.29 |
| Previous Close | $2.31 |
| Daily Range | $2.14 - $2.31 |
| 52-Week Range | $2.04 - $11.91 |
| Market Cap | $154.58M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 980,600 |
| Average Daily Volume | 0 |
SVNT
VS S&P 500 (SPY)
How do you think SVNT will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SVNT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SVNT News and Commentary
- New CEO = Dendreon Takeover Target? – The Motley Fool
- UPDATE: Dendreon Names New CEO To Spur Sales Growth For Provenge – SmartMoney
- Dendreon Picks Savient CEO Johnson To Succeed Gold At Helm – SmartMoney
- The 2 Biotechs Ramping Up Sales – The Motley Fool
- Dendreon Investors: Why Shares Are Soaring – The Motley Fool
- Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends – The Motley Fool
- The Worst Health-Care Stocks of 2011 – The Motley Fool
- Has Savient Pharmaceuticals Become the Perfect Stock? – The Motley Fool
- Avoid This Biotech Stock – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Opening View: DJIA Pointed Lower After Obama Speech; TXN, DNDN in Focus – NASDAQ
- Discouraged by Dendreon, Investors Shy From Drug Launches – The Motley Fool
- Here's Why Dendreon Isn't Like Other Biotechs – Minyanville
- Savient Pharmaceuticals Earnings Preview – The Motley Fool
- The Investors Quietly Betting Against You – The Motley Fool
- 7 Biotechs Near 52-Week Lows – The Motley Fool
- Rebound Ideas: 7 Oversold Stocks With Sufficient Cash to Cover Operating Expenses – SeekingAlpha
- Why Did My Stock Just Die? – The Motley Fool
- REW and RXL: The Paradox of Leveraged ETFs – SeekingAlpha
- Savient Sinks, but Will It Fall Further? – Minyanville
RSS Headlines
Fool UK
